SCHEMBL19344194

SCHEMBL19344194

C[C@H]1[C@@H](OC(C)(C)O)[C@H](c2ccc3c(N)ncnn23)O[C@@H]1CN1CC(F)(F)C[C@H]1CCN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22435096 0.91 — —
SCHEMBL23584783 0.86 — —
SCHEMBL19344138 0.85 POLRMT (0.34) —
SCHEMBL23584820 0.85 CSNK2A2 (0.32) —
SCHEMBL19344282 0.82 POLRMT (0.30) —
SCHEMBL19344170 0.81 POLRMT (0.30) —
SCHEMBL19344137 0.80 POLRMT (0.34) —
SCHEMBL19343958 0.80 CSNK2A2 (0.32) —
SCHEMBL23584787 0.80 PRMT5 (0.38) —
SCHEMBL19344087 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017153186-A1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-14 — — WO disclosed
Send feedback